EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Pathogenicity, Ovicidal Action, and Median Lethal Concentrations (LC 50 ) of Entomopathogenic Fungi against Exotic Spiralling Whitefly, Aleurodicus dispersus Russell

Boopathi Thangavel, Karuppuchamy Palaniappan, Kalyanasundaram Manickavasagam Pillai, Mohankumar Subbarayalu, Ravi Madhaiyan

Journal of Pathogens · 2013

DOI: 10.1155/2013/393787 ↗
AbstractBibliografische Angaben

Abstract

Biological control using entomopathogenic fungi could be a promising alternative to chemical control. Entomopathogenic fungi, Beauveria bassiana (Balsamo) Vuillemin, Metarhizium anisopliae (Metschnikoff) Sorokin, Lecanicillium lecanii (Zimmerm.) Zare and Gams, and Paecilomyces fumosoroseus (Wize) Brown and Smith, were tested for their pathogenicity, ovicidal effect, and median lethal concentrations (LC 50 ) against exotic spiralling whitefly, Aleurodicus dispersus Russell. The applications were made at the rate of 2 × 10 9 conidia mL −1 for evaluating the pathogenicity and ovicidal effect of entomopathogenic fungi against A. dispersus . The results of pathogenicity test showed that P. fumosoroseus (P1 strain) was highly pathogenic to A. dispersus recording 100% mortality at 15 days after treatment (DAT). M. anisopliae (M2 strain) had more ovicidal effect causing 37.3% egg mortality at 8 DAT. However, L. lecanii (L1 strain) caused minimum egg hatchability (23.2%) at 10 DAT as compared to control (92.6%). The lowest LC 50 produced by P. fumosoroseus (P1 strain) as 8.189 × 10 7 conidia mL −1 indicated higher virulence against A. dispersus . Hence, there is potential for use of entomopathogenic fungi in the field conditions as an alternate control method in combating the insect pests and other arthropod pests since they are considered natural mortality agents and are environmentally safe.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →